Health Canada requests Osiris additional information on stem cell therapy Prochymal
Health Canada has given Osiris 90 days to answer certain questions raised during the review. Osiris president and CEO Randal Mills said they intend to work with Health
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.